APA (7th ed.) Citation

Mizrahi, R., Kenk, M., Suridjan, I., Boileau, I., George, T. P., McKenzie, K., . . . Rusjan, P. (2014). Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use. Neuropsychopharmacology (New York, N.Y.), 39(6), 1479-1489. https://doi.org/10.1038/npp.2013.347

Chicago Style (17th ed.) Citation

Mizrahi, Romina, Miran Kenk, Ivonne Suridjan, Isabelle Boileau, Tony P. George, Kwame McKenzie, Alan A. Wilson, Sylvain Houle, and Pablo Rusjan. "Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and Without Concurrent Cannabis Use." Neuropsychopharmacology (New York, N.Y.) 39, no. 6 (2014): 1479-1489. https://doi.org/10.1038/npp.2013.347.

MLA (9th ed.) Citation

Mizrahi, Romina, et al. "Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and Without Concurrent Cannabis Use." Neuropsychopharmacology (New York, N.Y.), vol. 39, no. 6, 2014, pp. 1479-1489, https://doi.org/10.1038/npp.2013.347.